Type I and II Endometrial Cancers: Have They Different Risk Factors?Veronica Wendy Setiawan, Jennifer A. Doherty, Pamela J. Thompson et al.|Journal of Clinical Oncology|2013Cited by 833
H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolaseJichun Zhou, Yingqun Huang, Lihua Yang et al.|Nature Communications|2015Cited by 271
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancerRui Han, Lingeng Lu|Medical Oncology|2022Cited by 30
Antioxidant protein peroxiredoxin 6 suppresses the vascular inflammation, oxidative stress and endothelial dysfunction in angiotensin II-induced endotheliocyteDongni Li, Lingeng Lu|General Physiology and Biophysics|2020Cited by 13
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sitesJessie Y. Li, Gulden Menderes, Levent Mutlu et al.|Gynecologic Oncology Reports|2021Cited by 10